Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Debt Ratio: 2009-2016

Historic Debt Ratio for Gyre Therapeutics (GYRE) over the last 7 years, with Sep 2016 value amounting to 0.00.

  • Gyre Therapeutics' Debt Ratio fell 94.02% to 0.00 in Q3 2016 from the same period last year, while for Sep 2016 it was 0.00, marking a year-over-year decrease of 94.02%. This contributed to the annual value of 0.02 for FY2015, which is N/A change from last year.
  • Gyre Therapeutics' Debt Ratio amounted to 0.00 in Q3 2016, which was down 76.12% from 0.00 recorded in Q2 2016.
  • Over the past 5 years, Gyre Therapeutics' Debt Ratio peaked at 0.02 during Q4 2015, and registered a low of 0.00 during Q3 2016.
  • In the last 3 years, Gyre Therapeutics' Debt Ratio had a median value of 0.00 in 2014 and averaged 0.01.
  • Its Debt Ratio has fluctuated over the past 5 years, first soared by 120.39% in 2015, then crashed by 94.02% in 2016.
  • Quarterly analysis of 5 years shows Gyre Therapeutics' Debt Ratio stood at 0.01 in 2012, then fell by 25.70% to 0.01 in 2013, then plummeted by 51.91% to 0.00 in 2014, then spiked by 120.39% to 0.02 in 2015, then crashed by 94.02% to 0.00 in 2016.
  • Its Debt Ratio stands at 0.00 for Q3 2016, versus 0.00 for Q2 2016 and 0.00 for Q1 2016.